Obamacare Repeal May Be Delaying User-Fee Bills, Rep. DeGette Says
The House Energy and Commerce Committee Democrat says few in-depth member talks about user-fee bills have taken place because of a focus on Affordable Care Act repeal and replacement.
You may also be interested in...
After months of waiting on whether President Trump would pick a conventional FDA commissioner candidate or go off the beaten path, the White House appears to be taking the former approach. Trump is expected to nominate Scott Gottlieb, a George W. Bush administration FDA alum, physician and long-time conservative voice on health policy. Gottlieb will favor reduced regulatory burdens, and industry hopes he will help push forward a device user-fee reauthorization agreement.
As Obamacare repeal-and-replace plans begin to take shape in the Senate, not all of the legislative proposals include provisions to repeal the medical device tax, and fewer senators in the 2017-2018 Congress have signed on to support repeal of the tax than did in the early days of the prior Congress.
President Trump’s hiring freeze on civilian employees will exacerbate the Center for Drugs Evaluation & Research’s existing difficulties in recruiting and retaining qualified individuals. CDER is currently 591 positions under the hiring ceiling, include 50 open positions within CDER management.